Clinical trial: Interferon alpha-2b continuous long-term therapy vs. repeated 24-week cycles for re-treating chronic hepatitis C

Alimentary Pharmacology and Therapeutics

Volumn 27, Issue 5, 2008, Pages 422-432

  McHutchison, J G ^a,b   Patel, K ^b   Schiff, E R ^c   Gitlin, N ^d   Mur, R E ^e   Everson, G T ^f   Carithers Jr , R L ^g   Davis, G L ^h   Marcellin, P ⁱ   Shiffman, M L ^j   Harvey, J ^k   Albrecht, J K ^k  

^a DUKE CLINICAL RESEARCH INSTITUTE   (United States)

^b DUKE UNIVERSITY MEDICAL CENTER   (United States)

^c UNIVERSITY OF MIAMI MILLER SCHOOL OF MEDICINE   (United States)

^d EMORY UNIVERSITY SCHOOL OF MEDICINE   (United States)

^e HOSPITAL UNIVERSITARI VALL D HEBRON   (Spain)

^f UNIVERSITY OF COLORADO   (United States)

^g UNIVERSITY OF WASHINGTON MEDICAL CENTER   (United States)

^h UNIVERSITY OF FLORIDA COLLEGE OF MEDICINE   (United States)

ⁱ BEAUJON HOSPITAL   (France)

^j VIRGINIA COMMONWEALTH UNIVERSITY   (United States)

^k MERCK RESEARCH LABORATORIES   (United States)

more..

Author keywords

[No Author keywords available]

Indexed keywords

ALANINE AMINOTRANSFERASE; ALPHA2B INTERFERON; RECOMBINANT ALPHA2B INTERFERON; VIRUS RNA;

ABDOMINAL PAIN; ADULT; AGED; ALANINE AMINOTRANSFERASE BLOOD LEVEL; ALOPECIA; ANOREXIA; ANXIETY; ARTHRALGIA; ARTICLE; CLINICAL TRIAL; CONTINUOUS INFUSION; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; COUGHING; DEPRESSION; DIARRHEA; DOSAGE SCHEDULE COMPARISON; DRUG DOSE REDUCTION; DRUG DOSE TITRATION; DRUG EFFICACY; DRUG WITHDRAWAL; DRY SKIN; DYSPEPSIA; DYSPNEA; EMOTIONAL DISORDER; FATIGUE; FEMALE; FEVER; HEADACHE; HEPATITIS; HEPATITIS C; HEPATITIS C VIRUS; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; INJECTION SITE INFLAMMATION; INSOMNIA; IRRITABILITY; LIVER BIOPSY; LIVER FIBROSIS; LIVER NECROSIS; LONG TERM CARE; LOW DRUG DOSE; MAJOR CLINICAL STUDY; MALAISE; MALE; MULTICENTER STUDY; MULTIPLE CYCLE TREATMENT; MUSCULOSKELETAL PAIN; MYALGIA; NAUSEA; OPEN STUDY; PHARYNGITIS; PRIORITY JOURNAL; PRURITUS; RANDOMIZED CONTROLLED TRIAL; RASH; RELAPSE; RETREATMENT; RIGOR; SCORING SYSTEM; SIDE EFFECT; SINUSITIS; STATISTICAL ANALYSIS; TREATMENT OUTCOME; VOMITING;

ADOLESCENT; ADULT; AGED; ALANINE TRANSAMINASE; ANTIVIRAL AGENTS; ARTHRALGIA; BIOPSY; DRUG ADMINISTRATION SCHEDULE; FEMALE; FEVER; HEADACHE; HEPACIVIRUS; HEPATITIS C, CHRONIC; HUMANS; INTERFERON ALFA-2B; LIVER; MALE; MIDDLE AGED; MUSCLE WEAKNESS; RECURRENCE; RNA, VIRAL; TIME FACTORS;

EID: 38349185347     PISSN: 02692813     EISSN: 13652036     Source Type: Journal    
DOI: 10.1111/j.1365-2036.2007.03590.x     Document Type: Article

References (20)

1. World Health Organization. Hepatitis C (Fact Sheet No. 164. Revised October 2000). Available at: http://www.who.int/mediacentre/factsheets/fs164/en/ print.html, accessed on 12 May 2004.
2. Alter M, Kruszon-Moran D, Nainan O, et al. The prevalence of hepatitis C virus in the United States, 1988 through 1994. N Engl J Med 1999 341 : 556 62.
3. Detre K, Belle S, Lombardero M. Liver transplantation for chronic viral hepatitis. Viral Hepat Rev 1996 2 : 219 28.
4. Manns MP, McHutchison JG, Gordon SC, et al. Peginterferon alfa-2b plus ribavirin compared with interferon alfa-2b plus ribavirin for initial treatment of chronic hepatitis C: a randomised trial. Lancet 2001 358 : 958 65.
5. Fried MW, Shiffman ML, Reddy KR, et al. Peginterferon alfa-2a plus ribavirin for chronic hepatitis C virus infection. N Engl J Med 2002 347 : 975 82.
6. Poynard T, Bedossa P, Opolon P. Natural history of liver fibrosis progression in patients with chronic hepatitis C. The OBSVIRC, METAVIR, CLINIVIR, and DOSVIRC groups. Lancet 1997 349 : 825 32.
7. Poynard T, Ratziu V, Charlotte F, Goodman Z, McHutchison J, Albrecht J. Rates and risk factors of liver fibrosis progression in patients with chronic hepatitis C. J Hepatol 2001 34 : 730 9.
8. Shiffman ML, Di Bisceglie AM, Lindsay KL, et al. Peginterferon alfa-2a and ribavirin in patients with chronic hepatitis C who have failed prior treatment. Gastroenterology 2004 126 : 1015 23.
9. Poynard T, McHutchison J, Davis GL, et al. Impact of interferon alfa-2b and ribavirin on progression of liver fibrosis in patients with chronic hepatitis C. Hepatology 2000 32 : 1131 7.
10. Mallat A, Preaux A-M, Blazejewski S, Rosenbaum J, Dhumeaux D, Mavier P. Interferon alfa and gamma inhibit proliferation and collagen synthesis of human Ito cells in culture. Hepatology 1995 21 : 1003 10.
11. Inagaki Y, Nemoto T, Kushida M, et al. Interferon alfa down-regulates collagen gene transcription and suppresses experimental hepatic fibrosis in mice. Hepatology 2003 38 : 890 9.
12. Sobesky R, Mathurin P, Charlotte F, et al. Modeling the impact of interferon alfa treatment on liver fibrosis progression in chronic hepatitis C: a dynamic view. Gastroenterology 1999 116 : 378 86.
13. Shiffman ML, Hofmann CM, Contos MJ, et al. A randomized, controlled trial of maintenance interferon therapy for patients with chronic hepatitis C virus and persistent viremia. Gastroenterology 1999 117 : 1164 72.
14. Davis GL, Esteban-Mur R, Rustgi V, et al. Recombinant interferon alfa-2b alone or in combination with ribavirin for retreatment of interferon relapse in chronic hepatitis C. N Engl J Med 1998 339 : 1493 6.
15. Lau JYN, Davis GL, Brunson ME, et al. Hepatitis C virus infection in renal transplant recipients. Hepatology 1993 18 : 1027 31.
16. Pocock SJ, Simon R. Sequential treatment assignment with balancing for prognostic factors in the controlled clinical trial. Biometrics 1975 31 : 103 15.
17. Knodell RG, Ishak KG, Black WC, et al. Formulation and application of a numerical scoring system for assessing histological activity in asymptomatic chronic active hepatitis. Hepatology 1981 1 : 431 5.
18. Stuyver L, Rossau R, Wyseur A, Duhamel M, Vanderborght B, Van Heuverswyn H. Typing of hepatitis C virus isolates and characterization of new subtypes using a line probe assay. J Gen Virol 1993 74 : 1093 102.
19. Bedossa P, Dargere D, Paradis V. Sampling variability of liver fibrosis in chronic hepatitis C. Hepatology 2003 38 : 1449 57.
20. Regev A, Berho M, Jeffers LJ, et al. Sampling error and intraobserver variation in liver biopsy in patients with chronic HCV infection. Am J Gastroenterol 2002 97 : 2614 8.